Seres Therapeutics (MCRB) Notes Payables (2014 - 2022)

Seres Therapeutics has disclosed Notes Payables across 5 years of filings, most recently posting $456000.0 for Q4 2022.

• In Q4 2022, Notes Payables changed N/A year-over-year to $456000.0; the TTM figure through Dec 2022 stood at $456000.0 (changed N/A YoY), while the FY2022 annual figure was $456000.0, changed N/A from the prior year.
• Notes Payables came in at $456000.0 for Q4 2022 at Seres Therapeutics, down from $9.3 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $9.3 million in Q3 2021 to a low of $454000.0 in Q4 2020.
• Average Notes Payables over 3 years is $4.0 million, with a median of $3.3 million recorded in 2021.